Skip to main content

Find Clinical Trials

Home
Conditions
Genital Diseases, Female

Clinical trial condition

Genital Diseases, Female

Explore clinical trials studying Genital Diseases, Female. Study availability and eligibility vary by location and protocol.

7,683 public trials 1,512 recruiting studies

Refine in advanced search Browse all conditions

Genital Diseases, Female trial results

Completed

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

NCT00005842

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
Locations: Brooke Army Medical Center Fort Sam Houston, Texas, United States

Institute for Drug Development San Antonio, Texas, United States

View Trial Details

Completed

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer

NCT00003136

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

View Trial Details

Completed

Exercise and Healthy Diet or Standard Care in Patients in Remission From Stage I or Stage II Endometrial Cancer

NCT00732173

Conditions: Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Gene Therapy in Treating Patients With Ovarian Cancer

NCT00003588

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma

NCT00003778

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +16 more
Locations: University of Colorado Cancer Center Denver, Colorado, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer

NCT00257348

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Chao Family Comprehensive Cancer Center Orange, California, United States

View Trial Details

Completed

Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors

NCT01440504

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Centre François Baclesse Caen, France

View Trial Details

Completed

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

NCT00003439

Conditions: Adenocarcinoma, Adnexal Diseases, Anus Diseases, +54 more
Locations: University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer

NCT00002734

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations: University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States

View Trial Details

Completed

Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix

NCT00003377

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States

University of Chicago Cancer Research Center Chicago, Illinois, United States

Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States

Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees Camden, New Jersey, United States

View all 13 locations

View Trial Details